tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
Japanese Market

Towa Pharmaceutical Co (4553) Income Statement

Compare
0 Followers

Towa Pharmaceutical Co Income Statement

Last quarter (Q2 2026), Towa Pharmaceutical Co's total revenue was ¥65.33B, an increase of 7.38% from the same quarter last year. In Q2, Towa Pharmaceutical Co's net income was ¥5.70B. See Towa Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 259.59B¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B
Gross Profit
¥ 94.73B¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B
Operating Expenses
¥ 71.49B¥ 63.74B¥ 67.20B¥ 50.98B¥ 45.53B
Depreciation and Amortization
¥ 20.10B¥ 17.89B¥ 19.41B¥ 10.95B¥ 10.43B
EBITDA
¥ 48.05B¥ 35.54B¥ 25.14B¥ 29.49B¥ 29.34B
Operating Income
¥ 23.24B¥ 17.65B¥ 5.51B¥ 19.20B¥ 19.92B
Other Income/Expenses
¥ 3.09B¥ 6.81B¥ -909.00M¥ 3.04B¥ -1.20B
Pretax Income
¥ 26.33B¥ 24.46B¥ 4.61B¥ 22.25B¥ 18.73B
Net Income
¥ 18.99B¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B
Per Share Metrics
Basic EPS
¥ 385.70¥ 328.58¥ 44.72¥ 323.35¥ 283.62
Diluted EPS
¥ 385.70¥ 328.58¥ 44.72¥ 316.19¥ 271.93
Weighted Average Shares Outstanding
49.23M 49.22M 49.22M 49.22M 49.21M
Weighted Average Shares Outstanding (Diluted)
49.23M 49.22M 50.34M 50.32M 51.28M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History